Facts & Figures
Quality before costs, less willingness to do without
Pharma hub Switzerland 2030
show more articles
Every franc of value that the pharmaceutical industry creates generates an additional 73 cents of value in other sectors of Swiss industry.
Between 1990 and 2015 the mortality rate for breast cancer fell by 30%.
The pharmaceutical industry in Switzerland will also need attractive framework conditions in future, including legal certainty, open export markets and the availability of labour.
People in Switzerland benefit from access to high-quality healthcare provision. However, there is still a need for action and improvement in various areas.
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2020
More about the tasks and overriding aims of Interpharma
Latest information and media contacts for media representatives